![Edwin Rock](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Edwin Rock
Direttore Tecnico/Scientifico/R&S presso GLYCOMIMETICS, INC.
Patrimonio netto: 191 874 $ in data 30/06/2024
Profilo
Edwin P.
Rock is currently the Chief Medical Officer & Senior Vice President at GlycoMimetics, Inc. Prior to his current position, he served as the Chief Medical Officer at Partner Therapeutics, Inc. Dr. Rock completed his undergraduate degree at Swarthmore College and obtained his doctorate from Stanford University School of Medicine.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
GLYCOMIMETICS, INC.
1.06% | 21/06/2024 | 680 403 ( 1.06% ) | 191 874 $ | 30/06/2024 |
Posizioni attive di Edwin Rock
Società | Posizione | Inizio |
---|---|---|
GLYCOMIMETICS, INC. | Direttore Tecnico/Scientifico/R&S | 06/09/2022 |
Precedenti posizioni note di Edwin Rock
Società | Posizione | Fine |
---|---|---|
Partner Therapeutics, Inc.
![]() Partner Therapeutics, Inc. BiotechnologyHealth Technology Partner Therapeutics, Inc. develops and commercializes therapeutics that improves health and economic outcomes in the treatment of cancer. Its development focus spans the entire range of cancer therapy from primary treatments to supportive care. The company is headquartered in Boston, MA. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Edwin Rock
Swarthmore College | Undergraduate Degree |
Stanford University School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
GLYCOMIMETICS, INC. | Health Technology |
Aziende private | 1 |
---|---|
Partner Therapeutics, Inc.
![]() Partner Therapeutics, Inc. BiotechnologyHealth Technology Partner Therapeutics, Inc. develops and commercializes therapeutics that improves health and economic outcomes in the treatment of cancer. Its development focus spans the entire range of cancer therapy from primary treatments to supportive care. The company is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Edwin Rock